An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Trial Status: enrolling by invitation
This study will assess the long-term safety and efficacy of bilateral intra-parotid
administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late
xerostomia.
Inclusion Criteria
Received study drug in Study MGT-AQP1-201
Exclusion Criteria
Withdrew consent to participate in Study MGT-AQP1-201.
Additional locations may be listed on ClinicalTrials.gov for NCT06544798.
Locations matching your search criteria
United States
Iowa
Iowa City
University of Iowa/Holden Comprehensive Cancer Center
Status: Approved
Name Not Available
North Carolina
Chapel Hill
UNC Lineberger Comprehensive Cancer Center
Status: Active
Name Not Available
Individual participation in this study will last approximately 48 months for participants
who received AAV2-hAQP1 in Study MGT-AQP1-201 and at least 60 months for participants who